Literature DB >> 11309264

Structural requirements for voltage-dependent block of muscle sodium channels by phenol derivatives.

G Haeseler1, A Piepenbrink, J Bufler, R Dengler, J K Aronson, S Piepenbrock, M Leuwer.   

Abstract

We have studied the effects of four different phenol derivatives, with methyl and halogen substituents, on heterologously expressed human skeletal muscle sodium channels, in order to find structural determinants of blocking potency. All compounds blocked skeletal muscle sodium channels in a concentration-dependent manner. The methylated phenol 3-methylphenol and the halogenated phenol 4-chlorophenol blocked sodium currents on depolarization from -100 mV to 0 mV with IC(50) values of 2161 and 666 microM respectively. Methylation of the halogenated compound further increased potency, reducing the IC(50) to 268 microM in 2-methyl-4-chlorophenol and to 150 microM in 3,5-dimethyl-4-chlorophenol. Membrane depolarization before the test depolarization increased sodium channel blockade. When depolarizations were started from -70 mV or when a 2.5 s prepulse was introduced before the test pulse inducing slow inactivation, the IC(50) was reduced more than 3 fold in all compounds. The values of K(D) for the fast-inactivated state derived from drug-induced shifts in steady-state availability curves were 14 microM for 3,5-dimethyl-4-chlorophenol, 19 microM for 2-methyl-4-chlorophenol, 26 microM for 4-chlorophenol and 115 microM for 3-methylphenol. All compounds accelerated the current decay during depolarization and slowed recovery from fast inactivation. No relevant frequency-dependent block after depolarizing pulses applied at 10, 50 and 100 Hz was detected for any of the compounds. All the phenol derivatives that we examined are effective blockers of skeletal muscle sodium channels, especially in conditions that are associated with membrane depolarization. Blocking potency is increased by halogenation and by methylation with increasing numbers of methyl groups.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11309264      PMCID: PMC1572741          DOI: 10.1038/sj.bjp.0704024

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  21 in total

1.  Quantitative structure activity studies of antiarrhythmic properties in a series of lidocaine and procainamide derivatives.

Authors:  G R Ehring; J W Moyer; L M Hondeghem
Journal:  J Pharmacol Exp Ther       Date:  1988-02       Impact factor: 4.030

2.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

3.  Voltage-dependent blockade of normal and mutant muscle sodium channels by benzylalcohol.

Authors:  G Haeseler; M Mamarvar; J Bufler; R Dengler; H Hecker; J K Aronson; S Piepenbrock; M Leuwer
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

4.  Voltage-dependent block of normal and mutant muscle sodium channels by 4-Chloro-m-Cresol.

Authors:  G Haeseler; M Leuwer; J Kavan; A Würz; R Dengler; S Piepenbrock
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

5.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

6.  Dissecting lidocaine action: diethylamide and phenol mimic separate modes of lidocaine block of sodium channels from heart and skeletal muscle.

Authors:  G W Zamponi; R J French
Journal:  Biophys J       Date:  1993-12       Impact factor: 4.033

7.  Aminoalkyl structural requirements for interaction of lidocaine with the class I antiarrhythmic drug receptor on rat cardiac myocytes.

Authors:  R S Sheldon; R J Hill; M Taouis; L M Wilson
Journal:  Mol Pharmacol       Date:  1991-05       Impact factor: 4.436

8.  Chlorocresol: an activator of ryanodine receptor-mediated Ca2+ release.

Authors:  F Zorzato; E Scutari; V Tegazzin; E Clementi; S Treves
Journal:  Mol Pharmacol       Date:  1993-12       Impact factor: 4.436

Review 9.  Commentary: A revised view of local anesthetic action: what channel state is really stabilized?

Authors:  T Scheuer
Journal:  J Gen Physiol       Date:  1999-01       Impact factor: 4.086

10.  Lidocaine block of cardiac sodium channels.

Authors:  B P Bean; C J Cohen; R W Tsien
Journal:  J Gen Physiol       Date:  1983-05       Impact factor: 4.086

View more
  7 in total

1.  An improved model for the binding of lidocaine and structurally related local anaesthetics to fast-inactivated voltage-operated sodium channels, showing evidence of cooperativity.

Authors:  Martin Leuwer; Gertrud Haeseler; Hartmut Hecker; Johannes Bufler; Reinhard Dengler; Jeffrey K Aronson
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

2.  Inhibition of cardiac voltage-gated sodium channels by grape polyphenols.

Authors:  C H R Wallace; I Baczkó; L Jones; M Fercho; P E Light
Journal:  Br J Pharmacol       Date:  2006-10-03       Impact factor: 8.739

Review 3.  Modulation of sodium channels as pharmacological tool for pain therapy-highlights and gaps.

Authors:  Nilufar Foadi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-03-23       Impact factor: 3.000

4.  Structural features of phenol derivatives determining potency for activation of chloride currents via alpha(1) homomeric and alpha(1)beta heteromeric glycine receptors.

Authors:  Gertrud Haeseler; Jörg Ahrens; Klaus Krampfl; Johannes Bufler; Reinhard Dengler; Hartmut Hecker; Jeffrey K Aronson; Martin Leuwer
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

5.  High-affinity blockade of voltage-operated skeletal muscle and neuronal sodium channels by halogenated propofol analogues.

Authors:  G Haeseler; M Karst; N Foadi; S Gudehus; A Roeder; H Hecker; R Dengler; M Leuwer
Journal:  Br J Pharmacol       Date:  2008-06-23       Impact factor: 8.739

6.  A combination of topical antiseptics for the treatment of sore throat blocks voltage-gated neuronal sodium channels.

Authors:  Nilufar Foadi; Regina Campos de Oliveira; Vanessa Buchholz; Carsten Stoetzer; Florian Wegner; Igor Pilawski; Gertrud Haeseler; Martin Leuwer; Jörg Ahrens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-07-12       Impact factor: 3.000

7.  Topical antiseptics for the treatment of sore throat block voltage-gated neuronal sodium channels in a local anaesthetic-like manner.

Authors:  Vanessa Buchholz; Martin Leuwer; Jörg Ahrens; Nilufar Foadi; Klaus Krampfl; Gertrud Haeseler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-04-15       Impact factor: 3.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.